search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Sponsored by


News


NHS using Imperial spinout’s advanced prescription software to improve safety


Imperial spinout Dosium is working with the NHS to roll out a clinical decision support tool that provides dosage guidance to increase patient safety. The Touchdose solution from Dosium provides


doctors with dosage recommendations based on NICE-approved reference work with the British National Formulary, tailored to patient characteristics such as age, weight and sex. The product could reduce errors by 76.5% and time to prescribe by 20% according to a study, currently under peer review, by the Centre for Medication Safety and Service Quality. The study was authored by a team of


researchers including Calandra Feather from Imperial’s Department of Surgery and Cancer and Dosium, and Professor Bryony Dean Franklin, Director of the NIHR North West London Patient Safety Research Collaboration. Touchdose is now being piloted in West London Children’s Healthcare (WLCH), a clinical service that serves over half a million children and young people across the Chelsea and Westminster Hospital NHS Foundation Trust and Imperial College Healthcare NHS Trust. The initiative is supported by funding from


NHS England in a first-of-type partnership that aims to advance a new solution to the 237 million prescribing errors made across England each year. The software will be used initially in the


children’s A&E department at St Mary’s Hospital, an environment where the need for speed and accuracy is particularly acute, and subsequently


across five additional departments in WLCH. Dosium was co-founded by Dr. Nicholas Appelbaum, a medical doctor with a PhD in medication safety, to commercialise early R&D he carried out as clinical lead at the Helix Centre, a research lab for design and health in Imperial’s Institute of Global Health Innovation. Dr. Appelbaum says he developed the product in response to the “terrifying” experience of prescribing to children in emergency situations. He explained that although Dosium is valuable for improving prescribing safety across all populations, the company’s initial focus on paediatrics is due to the higher associated risks of this group. “Children are all different sizes and that makes


accurate prescribing harder and the error rate higher. The consequences of these errors are also greater because children are a vulnerable population. Paediatrics is where medical error has been most pernicious.” The functionality is a significant advance on the


electronic prescription software currently used by the NHS.


“It is 2024, yet in general, electronic prescribing


systems still can’t tell me, as a prescriber, what the correct dose is for a given medication, factoring in my patient’s characteristics and the condition for which I am treating them,” said Dr. Appelbaum. Dosium has received investment from the Royal


Pharmaceutical Society, which is represented on Dosium’s board. Researchers will now use the WLCH pilot to clinically evaluate the product.


Drones fly blood packs in UK first


Blood packs have been successfully flown by drone in a series of ‘beyond visual line of sight’ flights, for the first time in the UK. In a research study to check the viability


of flying blood via drone, run jointly by NHS Blood and Transplant (NHSBT) and medical logistics company Apian, ten units of packed blood cells were transported on a 68km journey across Northumbria’s skies, while an identical ten packs were transported via road. After assessment, results showed both sets remained viable, with no significant difference in the biochemical or haematological profiles of the blood, which determine if it has maintained quality and can be used for clinical purposes. The study was the first in a series of NHS


trials to ascertain the feasibility and safety of delivering medical supplies via drone, which can be faster and more environmentally friendly than road travel.


IS THE NEW WAY The ultimate cleaning & disinfectant wipe, compatible with over 450 medical devices


Available to order now via the NHSSC VJT512 For more information, write to us at contact@pdi-emea.com


October 2024 I www.clinicalservicesjournal.com 11


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68